Literature DB >> 12206968

West Nile virus.

Grant L Campbell1, Anthony A Marfin, Robert S Lanciotti, Duane J Gubler.   

Abstract

West Nile (WN) virus is a mosquito-borne flavivirus and human, equine, and avian neuropathogen. The virus is indigenous to Africa, Asia, Europe, and Australia, and has recently caused large epidemics in Romania, Russia, and Israel. Birds are the natural reservoir (amplifying) hosts, and WN virus is maintained in nature in a mosquito-bird-mosquito transmission cycle primarily involving Culex sp mosquitoes. WN virus was recently introduced to North America, where it was first detected in 1999 during an epidemic of meningoencephalitis in New York City. During 1999-2002, the virus extended its range throughout much of the eastern parts of the USA, and its range within the western hemisphere is expected to continue to expand. During 1999-2001, 142 cases of neuroinvasive WN viral disease of the central nervous system (including 18 fatalities), and seven cases of uncomplicated WN fever were reported in the USA. Most human WN viral infections are subclinical but clinical infections can range in severity from uncomplicated WN fever to fatal meningoencephalitis; the incidence of severe neuroinvasive disease and death increase with age. Serology remains the mainstay of laboratory diagnosis. No WN virus-specific treatment or vaccine is available. Prevention depends on organised, sustained vector mosquito control, and public education.

Entities:  

Mesh:

Year:  2002        PMID: 12206968     DOI: 10.1016/s1473-3099(02)00368-7

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  234 in total

Review 1.  Role of γδ T cells in West Nile virus-induced encephalitis: friend or foe?

Authors:  Tian Wang
Journal:  J Neuroimmunol       Date:  2011-11-10       Impact factor: 3.478

Review 2.  West Nile virus.

Authors:  Bob Nosal; Rosanan Pellizzari
Journal:  CMAJ       Date:  2003-05-27       Impact factor: 8.262

3.  Use of an internal positive control in a multiplex reverse transcription-PCR to detect West Nile virus RNA in mosquito pools.

Authors:  Diane L Eisler; Alan McNabb; Danielle R Jorgensen; Judith L Isaac-Renton
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

4.  Evaluations of commercial West Nile virus immunoglobulin G (IgG) and IgM enzyme immunoassays show the value of continuous validation.

Authors:  Annette K Malan; Thomas B Martins; Harry R Hill; Christine M Litwin
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

5.  Using conservation of pattern to estimate spatial parameters from a single snapshot.

Authors:  Matt J Keeling; Stephen P Brooks; Christopher A Gilligan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-07       Impact factor: 11.205

Review 6.  West Nile virus: a growing concern?

Authors:  L Hannah Gould; Erol Fikrig
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

7.  Host feeding patterns of established and potential mosquito vectors of West Nile virus in the eastern United States.

Authors:  Charles S Apperson; Hassan K Hassan; Bruce A Harrison; Harry M Savage; Stephen E Aspen; Ary Farajollahi; Wayne Crans; Thomas J Daniels; Richard C Falco; Mark Benedict; Michael Anderson; Larry McMillen; Thomas R Unnasch
Journal:  Vector Borne Zoonotic Dis       Date:  2004       Impact factor: 2.133

Review 8.  West Nile Virus: biology, transmission, and human infection.

Authors:  Tonya M Colpitts; Michael J Conway; Ruth R Montgomery; Erol Fikrig
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

9.  The roles of mosquito and bird communities on the prevalence of West Nile virus in urban wetland and residential habitats.

Authors:  Brian J Johnson; Kristin Munafo; Laura Shappell; Nellie Tsipoura; Mark Robson; Joan Ehrenfeld; Michael V K Sukhdeo
Journal:  Urban Ecosyst       Date:  2012-09       Impact factor: 3.005

10.  In vitro analysis of MyD88-mediated cellular immune response to West Nile virus mutant strain infection.

Authors:  Guorui Xie; Melissa C Whiteman; Jason A Wicker; Alan D T Barrett; Tian Wang
Journal:  J Vis Exp       Date:  2014-11-27       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.